中文名称: TBB
英文名称: TBB
CAS No: 17374-26-4
分子式: C6HBr4N3
分子量: 434.71
EINEC: 231634
T10774 TBB ≥98% (psaitong)
包装规格:
250mg in glass bottle
溶解性:
溶于DMSO(≥ 100 mg/mL)
产品描述:

基本信息

产品编号:T10774

产品名称:TBB

CAS:

17374-26-4

 

储存条件

粉末

2-8℃

四年

 

 

分子式:

C6HBr4N3

溶于液体

-80℃

两年

分子量

434.71

-20℃

一个月

化学名: 

4,5,6,7-Tetrabromo-2-azabenzimidazole

 

Solubility (25°C)

 

体外

DMSO

86 mg/mL (197.83mM)

Ethanol

 

Water

 

体内

现配现用

 

1mg/ml表示微溶或不溶。

普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。

 

制备储备液

 

浓度

 

溶液体积

质量

 

1mg

 

5mg

 

10mg

1mM

2.3004mL

11.5019mL

23.0038mL

5mM

0.4601mL

2.3004mL

4.6008mL

10mM

0.2300mL

1.1502mL

2.3004mL

50mM

0.0460mL

0.2300mL

0.4601mL

 

生物活性

产品描述

一种可渗透细胞,ATP竞争型的 CK2 抑制剂。

靶点/IC50

CK2 
(Cell-free assay)

0.4μM(Ki)

CK1 
(Cel-free assay)

47μM(Ki)

体外研究

Investigation of the inhibitory power of TBB with a panel of 33 protein kinases shows highest potency for CK2 (casein kinase 2) (human CK2: IC50=1.6μM at 100μM ATP). TBB also inhibits three other kinases with less potency: CDK2 (IC50=15.6μM), phosphorylase kinase (IC50=8.7μM) and glycogen synthase kinase 3β (GSK3β) (IC50=11.2μM). All other kinases tested have IC50 values 50-fold greater than that for CK2. The viability of the androgen insensitive PC-3 cells may be diminished by TBB (60μM TBB) acting either alone or combined with anticancer agents CPT or TRAIL when a proper time schedule of the administration is applied. The time schedule-dependent activity of TBB does not come from its effect on apoptosis in PC-3 cells. TBB is an ATP/GTP competitive inhibitor of protein kinase casein kinase-2 (CK2), has been examined against a panel of 33 protein kinases, either Ser/Thr- or Tyr-specific. In the presence of 10 μM TBB (and 100μM ATP) only CK2 is drastically inhibited (>85%) whereas three kinases (phosphorylase kinase, glycogen synthase kinase 3L and cyclin-dependent kinase 2/cyclin A) underwent moderate inhibition, with IC50 values one-two orders of magnitude higher than CK2 (IC50=0.9μM). TBB

also inhibits endogenous CK2 in cultured Jurkat cells.

体内研究

The extent of retinal neovascularization in a mouse OIR model is reduced by approximately 60% after treatment with TBB (6 days at 60 mg/kg per day).

 

推荐实验方法(仅供参考)

细胞实验:

Cell Assay

PC-3 or HeLa cells are cultured routinely in RPMI-1640 and DMEM media, respectively, which are supplemented with 10% FBS, Penicillin (100 U/mL) and Streptomycin (100μg/mL) at 37°C in a humidified atmosphere of 5% CO2. Cells are seeded at 5×104  cells/well (PC-3) or 2×104 (HeLa) in 24-wells plates and cultured for 72 h. TBB (final concentration 60μM), CPT (final concentration 5.8nM), 2-deoxyglucose (2-DG; final concentration 0.5mM) or TRAIL (final concentration 13.3ng/mL) are added to the medium individually or in a combination and the cells are cultured for additional time, indicated on each figure. After treatment, the medium with the agent is removed and 500μL of MTT mixture (0.5mg/mL for PC-3 and 5.0mg/mL for HeLa cells in medium without phenol red) is added to each well and incubated for an additional 1 h at 37°C. The formazan crystals are diluted in 250μL of DMSO. The absorbance is measured at 570nm.

 

动物实验:

 

Animal Administration

Mice

The heterozygous C57BL/6J mice are used. Emodin and TBB are injected intraperitoneally in volumes of 50μL or less per mouse at doses of 15 to 30mg/kg body weight, twice daily, starting from day 11. Control mice are injected with PEG-Tween vehicle alone.

保存条件:
2-8℃
UN码:
HazardClass:
危害声明:
安全说明:
搜索质检报告(COA)
参考文献 & 客户发表文献

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)

摩尔浓度计算公式

  • =
    *
    *
    *选择对应的单位 *空出希望得到的变量,填写另外两个变量

用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积

稀释公式

稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )

  • * = *

连续稀释计算器方程

  • 连续稀释

  • 初始浓度:
  • 稀释倍数:
  • 计算结果

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):